Leviton Lighting recently announced it has entered into a licensing agreement with GE Current to acquire its 365DisInFxTM UVA technology, a new disinfection lighting technology, for incorporation into the company’s lighting portfolio. The patented technology can help to disinfect surfaces in occupied spaces, with immediate applications in healthcare, commercial, and educational facilities via Leviton Lighting & Controls luminaires.
Current’s 365DisInFx UVA technology uses UV-A LEDs to reduce the potential spread of certain common infection-causing pathogens in virtually any space. This allows for spaces to be disinfected in real time while occupants are present. The UVA light emitted from the luminaire is invisible to the human eye. When installed and used as directed, luminaires incorporating this disinfection technology are designed to meet IEC photobiological safety standard 62471.
365DisInFX UVA technology works by delivering light in the 300nm spectrum that excites certain molecules found inside microbes. This excitation causes reactions that result in oxidative cell damage to pathogens, rendering them inactive. This patented technology has been demonstrated as being effective against common pathogens, including Staphylococcus aureus (including MRSA), Enterococcus faecalis, Escherichia coli, Acintobacter baumannii, Pseudomonas aeruginosa, and Candida albicans and aurias, as well as on pathogen analogs such as bacteriophage MS2.
You must be logged in to post a comment.